Concepedia

Karin Schlegelmilch

KS

8

Publications

2.8K

Citations

8

H-Index

2011

Active since

Affiliations

Harvard University(Current)

Boston Children's Hospital

Harvard Stem Cell Institute

The Francis Crick Institute

Freie Universität Berlin

Karin Schlegelmilch is an author at Harvard University specializing in cell biology, medicine, and molecular signaling.

ORCID

Top concepts

Publications per year

2011–2023

8

Publications

8

Yap1 Acts Downstream of α-Catenin to Control Epidermal Proliferation

Karin Schlegelmilch, Morvarid Mohseni, Oktay Kirak et al. · Cell · 2011 · 1.1K citations · Full text

, , +4

YAP1, the nuclear target of Hippo signaling, stimulates heart growth through cardiomyocyte proliferation but not hypertrophy

Alexander von Gise, Zhiqiang Lin, Karin Schlegelmilch et al. · Proceedings of the National Academy of Sciences · 2012 · 574 citations · Full text

YAP mediates crosstalk between the Hippo and PI(3)K–TOR pathways by suppressing PTEN via miR-29

Karen Tumaneng, Karin Schlegelmilch, Ryan C. Russell et al. · Nature Cell Biology · 2012 · 451 citations · Full text

, , +10

Hippo Signaling Regulates Microprocessor and Links Cell-Density-Dependent miRNA Biogenesis to Cancer

Masaki Mori, Robinson Triboulet, Morvarid Mohseni et al. · Cell · 2014 · 332 citations · Full text

, , +6

A FIJI macro for quantifying pattern in extracellular matrix

Esther Wershof, Danielle Park, David J. Barry et al. · Life Science Alliance · 2021 · 157 citations · Full text

, , +22

Rows per page

1–5 of 8